Kegg medicus dgroup
| DG02855 | |
| DG番号 | DG02855 |
| 分類 | DGroup |
| 名称 | CYP2E1 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | DG00321 Carvedilol D00255 Carvedilol (JP18/USP/INN) D03415 Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN) D00592 Dapsone (USP); Diaphenylsulfone (JAN) DG00974 Caffeine D00528 Caffeine (USP); Anhydrous caffeine (JP18) D01453 Caffeine hydrate (JP18) D07603 Caffeine citrate (USP) D09785 Delamanid (JAN/USAN) DG01414 Selumetinib D09666 Selumetinib (USAN/INN) D10024 Selumetinib sulfate (JAN/USAN) D01583 Pirfenidone (JAN/USAN/INN) D00542 Halothane (JP18/USP/INN) D00543 Enflurane (JP18/USP/INN) D00544 Methoxyflurane (USP/INN) DG00837 Naratriptan D08255 Naratriptan (INN) D00674 Naratriptan hydrochloride (JAN/USP) D11150 Cenobamate (USAN/INN) D02624 Eszopiclone (JAN/USP/INN) DG00926 Dexmedetomidine D00514 Dexmedetomidine (USAN/INN) D01205 Dexmedetomidine hydrochloride (JAN/USP) D02311 Acetone (NF) |
| 上位グループ | Metabolizing enzyme substrate |
| 注釈1 | - |
| 注釈2 | - |